Company
Type6
transformative medicines against kinase-addicted cancers
Also known as Type6 Therapeutics, Type6 Therapeutics, Inc
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Type6 Therapeutics, Inc
Claim, correct or request removal
Record updated 28 September 2026
About
Empowered by our purpose-built library of bivalent probes, we develop small-molecule therapeutics that engage disease-driving kinases where they are most vulnerable: their idle OFF-states.
Products
- Web
- CDK2i
- Other
- CDK2i lead program
Loading relationship preview